Stroke Flashcards
meningeal signs: rapid onset of headache with nuchal rigidity, headache and photophobia
subarachnoid haemorrhage or meningitis
initial evaluation
primary survey
identify risk factors for stroke, including presence of carotid bruits
determine time of onset and last known normal
investigations
serum glucose, vitals
ECG
FBC, INR, APTT, UECs, trops
?urine drug screen and BAL
lab studies should not delay imaging for patients with acute stroke
imaging
Non-contrast head CT to rule out haemorrhage before administering thrombolytic therapy
diffusion-weighted MRI
or CTA
if imaging is negative but suspicion for sub arachnoid haemorrhage remains high
Lumbar puncture - CSF may show xanthochromia
the presence of bilirubin in the CSF secondary to the breakdown of RBCs resulting in yellow discolouration
may be falsely negative in the first 12 hours of symptoms onset as xanthochromia is a late sign
findings of ischaemic stroke on non contrast CT
hyperdense MCA sign (suggesting presence of a thrombus)
effaceemnt of sulci
loss of cortico-medulllary differentiation
oedema
findings on CT for intracranial haemorrhage
hyperdense lesion within cerebral parenchyma
findings on non contrast head CT for subarachnoid haemorrhage
extensive area of hyperdense signals around the circle of willis
treatment options for ishcaemic stroke
- tPA (tissue plasminogen activator) if within 4.5 hours on onset of symptoms
- endovascular thrombectomy within 6 hours
- aspirin within 48 hours
tissue plasminogen activator
a serine protease found on endothelial cells of blood vessels
catalyses the conversion of plasminogen to plasmin, which is the main enzyme responsible for clot breakdown
recombinant tissue plasminogen activators (eg. alteplase, reteplase, tenecteplase) are used as thrombolytics in patients with acute coronary syndrome, pulmonary embolism, or ischaemic stroke
intravenous thrombolysis process
IV alteplase
if within 4.5 hours of onset of symptoms and as soon as possible
lower BP to below 185/110
endovascular thrombectomy
when the stroke is due to the occlusion of a large vessel
within 6 hours of symptom onset
what kinds of patients usually get endovascular thrombectomy
eligible patients are usually a subset of those for whom alteplase is indicated, and they can have both surgery and alteplase
endovascular thrombectomy may also be appropriate for those for whom alteplase is contraindicated (eg. patients taking anticoagulants) or those presenting too late for alteplase (between 4.5 hours and 6 hours)
endovascular thrombectomy may also be used for some patients who present up to 24 hours if there is occluded large vessel and salvageable brain tissue
general measures in acute ischemic stroke
assess swallow ability before giving oral drugs, if the patient has difficulty swallowing then make them nil by mouth and refer to speech pathology
avoid blood pressure lowering drugs except for patients with malignant hypertension or to lower blood pressure for alteplase
give supplimental oxygen if hypoxic
VTE prophylaxis
treatment for intracerebral haemorrhage
reversal of coagulopathy eg. cease anticoagulant
urgently lower BP to reduce hematoma expansion to <140
surgical intervention to evacuate the hematoma may be considered
symptoms of subarachnoid haemorrhage
75% present with acute severe headache, the rest present with LOC
mortality is high
many patients die before reaching the hospital
sentinel bleed
minor subarachnoid bleed occurring before the main rupture
sudden headache several weeks before the acute event
treatment of subarachnoid haemorrhage
patients are managed with a neurosurgeon
most subarachnoid haemorrhages are due to ruptured intracranial aneurysm
inconclusive non contrast CT with thunderclap headache
lumber puncture for sub arachnoid haemorrhage
if a non contrast CT shows no haemorrhage
ischaemic stroke
is the patient elligible for tPA
is it <4.5 hours from symptom onset -> IV tPA
then consider antiplatelet therapy and supportive management
and initiate secondary prevention